Kurt Landgraf and Du Pont Merck Pharmaceutical Co. (A, B)

Authors: Gentile, Mary C.; Grant, Sarah B.
Source: Harvard Business School
Year: 1995
Number of pages: 24, 3

download available.  details below.

[This document has not yet been rated] [You must be signed in as faculty to rate this document]   2269 views


Kurt Landgraf, newly named CEO of Du Pont Merck Pharmaceutical Co., addresses complaints of discrimination from African-American scientists in R&D during significant downsizing and dramatic changes within the pharmaceutical industry.

Case Available to Faculty Only. Faculty Member? Sign in / Register Here

This case is available for purchase from Harvard Business School Publishing Reference #: 394202, 395035

Search for
Teaching Materials